Intersect ENT

Acquired

PROPEL™ Sinus Implant

Public · Menlo Park, United States · Founded 2003 · $60.0M raised

Employees
201–500
Founded
2003
Business Model
B2B
Total Funding
$60.0M
Last Round
$30.0M Series DFeb 2013
Rounds
2
Type
Public
Acquired by
MedtronicAug 2021

About

Intersect ENT was a Menlo Park, California-based medical device company that developed and commercialized drug-eluting sinus implants, including the PROPEL and SINUVA products, designed to improve outcomes for ENT surgical patients. Founded in 2003, it was publicly traded before being acquired by Medtronic in May 2022 for approximately $1.1 billion.

Summary

Intersect ENT is a Biotech company based in Menlo Park, United States, founded in 2003. It has raised $60.0M in total across 2 rounds, most recently a $30.0M Series D round in Feb 2013. Investors include Medtronic, Kleiner Perkins and Shiv Chaudhary.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

AcquisitionAug 2021
$936.0M

Sign up to see all 4 rounds

Series C through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Intersect ENT on Indexed.vc
<a href="https://indexed.vc/companies/intersect-ent"><img src="https://indexed.vc/api/badge/company/intersect-ent" alt="Intersect ENT on Indexed.vc" width="260" height="76" /></a>